Money raised goes to the National Breast Cancer Foundation, which helps provide funds for research and treatments developed by Australian Oncologists, and enables them to focus on work that will lead to the next major breakthrough.
For example, Associate Professor Sherene Loi, MD, PhD leads a research laboratory that focuses on the genomic and immune interface in breast cancer patients. Her main interest is the development of sophisticated and practical drug treatments. Currently, she is focused on combination targeted and immune therapies for breast cancer patients.
“I believe that understanding the immune and genetic makeup of a person’s breast cancer will help advance our understanding of its clinical implications as well as speed up clinical trials progress,” Professor Loi says.
These much-needed funds will also help Associate Professor Elgene Lim, MD, PhD, in his research into overcoming resistance to the hormone treatments used on the largest subtype of breast cancer – estrogen receptor positive breast cancer.
He believes that no one individual or a specific technology has the answer; collaboration between scientists, doctors and patients is the key to success in establishing a pipeline from discovery right through to clinical trials.